---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42438632.md"
description: "The innovation drug going global and CXO sector has never truly cooled down this year. Names like $WUXI XDC(02268.HK), $PHARMARON(03759.HK), $ANTENGENE-B(06996.HK), and $EVEREST MED(01952.HK) have all popped up together again. The potential for pipeline and orders is still there, and the sector's spark could flare up again at any moment."
datetime: "2026-07-06T10:52:58.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42438632.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42438632.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42438632.md)
author: "[执笔画乾坤--Justin](https://longbridge.com/en/profiles/26727999.md)"
---

# The innovation drug going global and CXO sector ha…


### Related Stocks

- [02268.HK](https://longbridge.com/en/quote/02268.HK.md)
- [03759.HK](https://longbridge.com/en/quote/03759.HK.md)
- [06996.HK](https://longbridge.com/en/quote/06996.HK.md)
- [01952.HK](https://longbridge.com/en/quote/01952.HK.md)
- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)